|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10070 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-OTOA/DFNB22 |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human OTOA/DFNB22 |
、常染色體隱性遺傳22抗體規(guī)格 英文名稱 Anti-OTOA/DFNB22
中文名稱 、常染色體隱性遺傳22抗體規(guī)格
別 名 Cancer/testis antigen 108; CT108; Deafness, autosomal recessive 22; DFNB22; OTOA; OTOAN_HUMAN; Otoancorin.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 神經(jīng)生物學(xué) 細(xì)胞粘附分子 細(xì)胞外基質(zhì)
蛋白分子量 predicted molecular weight: 122kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human OTOA/DFNB22
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
、常染色體隱性遺傳22抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Otoancorin, also known as OTOA, CT108 or DFNB22, is a 1,153 amino acid protein belonging to the stereocilin family. Expressed in the inner ear and restricted to the interface between the apical surface of sensory epithelia, otoancorin is suggested to act as an adhesion molecule. Otoancorin ensures the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in the gene encoding otoancorin leads to deafness autosomal recessive type 22 (DFNB22), which is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain or the area of the brain that receives sound information. Existing as three alternatively spliced isoforms, otoancorin is encoded by a gene located on human chromosome 16p12.2.
Function : May act as an adhesion molecule.
Subcellular Location : Apical cell membrane. Secreted > extracellular space > extracellular matrix. At the interface between the apical surface of the epithelia and the overlying acellular gel of the tectorial and otoconial membranes.
DISEASE : Defects in OTOA are the cause of deafness autosomal recessive type 22 (DFNB22) [MIM:607039]. DFNB22 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
Similarity : Belongs to the stereocilin family.
Database links : UniProtKB/Swiss-Prot: Q7RTW8.1
實驗流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
、常染色體隱性遺傳22抗體規(guī)格 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
DPP IV (Human dipeptidyl peptldase IV ) ELISA Kit 人二肽基肽酶ⅣMulti-class antibodies規(guī)格： 48T
Anti-MT-ND1 NADH復(fù)合體1抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh IFN-Alpha 2b/Interferon alpha 2/INFA2 干擾素α2b抗體 規(guī)格 0.1ml
TRAb(Mouse thyroid stimulating hormone receptor antidoby)ELISA Kit 小鼠抗促甲狀腺素受體抗體 96T
PGC1 alpha + beta 英文名稱： 過氧化物酶體增殖物激活受體γ輔激活子1α+β抗體 0.1ml
CPB2 英文名稱： 胰羧肽酶B2抗體 0.2ml
Anti-MT-ND1 NADH復(fù)合體1抗體Multi-class antibodies規(guī)格： 0.2ml
CTGF 人結(jié)締組織生長因子Multi-class antibodies規(guī)格： 48T
Anti(c-phycocyanin C-藻藍(lán)素/藻藍(lán)蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh NME5/IPIA beta P53誘導(dǎo)細(xì)胞凋亡抑制蛋白抗體 規(guī)格 0.2ml
Human macrophage stimulating protein,MSP ELISA Kit 人巨噬細(xì)胞刺激蛋白 96T
TNMD 英文名稱： 腱調(diào)蛋白抗體(軟骨調(diào)節(jié)素樣1蛋白) 0.2ml
phospho-CSK (Ser364) 英文名稱： 磷酸化酪酸激酶C-SRC抗體 0.1ml
Anti(c-phycocyanin C-藻藍(lán)素/藻藍(lán)蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
PLAU/uPA (Plasminogen activator,urokinase) 尿激酶型纖溶酶原激活因子(多肽)Multi-class antibodies規(guī)格： 0.5mg
Anti-AVPR2 精氨酸加壓素受體2抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-AKT2 (Ser474) 磷酸化蛋白激酶B2抗體 規(guī)格 0.1ml
Myeloperoxidase 濃縮液 0.1ml 進(jìn)口分裝
UGDH 英文名稱： 尿苷二磷酸葡萄糖脫氫酶抗體 0.2ml
DNAJC3 英文名稱： 干擾素誘導(dǎo)蛋白p58ipk抗體 0.1ml
Anti-AVPR2 精氨酸加壓素受體2抗體Multi-class antibodies規(guī)格： 0.2ml
CTF1 Protein Human 重組人 Cardioophin-1 / CTF1 蛋白
JF305 *癌
IFNA14 Others Mouse 小鼠 IFNA14 / Ierferon alpha-14 人細(xì)胞裂解液 (陽性對照)
DU 145人細(xì)胞 DU 145 human prostate cancer cell F-12+10%FBS
豚鼠皮膚細(xì)胞;GP-S1
小鼠神經(jīng)皮質(zhì)細(xì)胞(MN-c)(1×106) LncaP, 人細(xì)胞 Human
CL-0348Hce-8693(人盲腸腺癌細(xì)胞(未分化))5×106cells/瓶×2
B3GALT5 Others Human 人 B3GALT5 人細(xì)胞裂解液 (陽性對照)
人氣管上皮細(xì)胞總RNAHTEpiC NA
盤羊皮膚細(xì)胞;OAM-S1 大鼠成肌細(xì)胞，L6細(xì)胞 TM4細(xì)胞，正常小鼠Leydig細(xì)胞
人皮膚成纖維樣細(xì)胞;HSF2
HA Others H5N1 甲型 H5N1 (A/duck/Laos/3295/2006) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對照)
、常染色體隱性遺傳22抗體規(guī)格 CTF1 Protein Human 重組人 Cardioophin-1 / CTF1 蛋白
JF305 *癌
IFNA14 Others Mouse 小鼠 IFNA14 / Ierferon alpha-14 人細(xì)胞裂解液 (陽性對照)
DU 145人細(xì)胞 DU 145 human prostate cancer cell F-12+10%FBS
豚鼠皮膚細(xì)胞;GP-S1
小鼠神經(jīng)皮質(zhì)細(xì)胞(MN-c)(1×106) LncaP, 人細(xì)胞 Human
技術(shù)外包服務(wù):
★、常染色體隱性遺傳22抗體規(guī)格 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
